share_log

Fulcrum Therapeutics | 8-K: Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023

SEC announcement ·  May 15, 2023 19:06
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.